H&P hires Eammon Vize as COO
This article was originally published in Scrip
H&P Industries, a manufacturer of over-the-counter drug products, has appointed Eammon Vize chief operating officer, reporting to H&P president Eric Haertle. Mr Vize has over 20 years' experience in the pharmaceutical and biotechnology fields, mostly with Abbott Laboratories.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.